The FDA has granted a de novo request for Procept Biorobotics Inc.'s Aquabeam system for the resection and removal of prostate tissue for the treatment of lower urinary tract symptoms (LUTS) as a ...
Procept had weak results on adding fewer than expected Aquabeam devices in Q1 of 2023, leading to a fall in the shares. Procept has strong potential in urology where its Aquablation technology has ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety ...
Delray Medical Center is the first hospital in Palm Beach and Broward Counties to offer the AquaBeam Robotic System Aquablation therapy for treatment of lower urinary tract symptoms (LUTS) and benign ...
EVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics ® announce a significant milestone in access to treatment of Benign Prostatic ...
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that three-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results